— Know what they know.
Not Investment Advice

CTEV NYSE

Claritev Corporation
1W: +1.1% 1M: +0.7% 3M: -3.3% YTD: -33.2% 1Y: -67.5% 3Y: -63.0% 5Y: -88.9%
$22.65
+1.11 (+5.15%)
 
Weekly Expected Move ±8.6%
$19 $21 $24 $26 $28
NYSE · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 40 · $383.9M mcap · 7M float · 2.16% daily turnover · Short 45% of daily vol
Credit Risk of going bust: higher than 96% of companies Debt: 92.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $19.38 (down 14%), Claritev Corporation would be worth roughly what it owes.
Total debt $4.62B against a stock market value of $383.9M.
Distance to default 0.10 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.32B (short-term plus half of long-term), stock volatility 127.1%; Altman Z'' -1.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Cash Flow Trends

Operating Cash Flow
$117M +9.0% ▲
5Y CAGR: -20.8%
Capital Expenditures
$130M -9.7% ▼
5Y CAGR: +12.8%
Free Cash Flow
-$12M -16.8% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$1M +97.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$102M-$573M-$92M-$1.6B-$284M
Depreciation & Amort.$424M$416M$426M$436M$445M
Stock-Based Comp.$18M$0$0$27M$28M
Change in Working Capital-$47M$55M-$22M-$14M-$29M
Other Non-Cash Items-$93M$589M-$26M$1.5B$86M
Operating Cash Flow$405M$372M$172M$108M$117M
— Investing Activities —
Capital Expenditures-$85M-$90M-$109M-$118M-$130M
Acquisitions (Net)-$149M$0-$141M$0$0
Investment Purchases$0-$15M$0$0$0
Investment Sales$0$289K$0$0$16M
Other Investing$6M$0$0$0-$7M
Investing Cash Flow-$228M-$104M-$250M-$118M-$121M
— Financing Activities —
Net Debt Issuance-$11M-$13M-$166M-$28M$5M
Stock Repurchased-$104M-$100M-$15M-$10M$0
Dividends Paid$0$0$0$0$0
Other Financing$0-$2M-$465K-$3M-$4M
Financing Cash Flow-$115M-$116M-$181M-$41M$2M
Net Change in Cash$62M$152M-$259M-$52M-$1M
Cash End of Period$188M$341M$81M$30M$28M
Free Cash Flow$320M$283M$63M-$11M-$12M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms